Blood is a bodily fluid that is vital for a number of life functions in animals. To a first approximation, blood is a mildly alkaline aqueous fluid (plasma) in which a large number of free-floating red cells (erythrocytes), white cells (leucocytes), and platelets are suspended. The primary function of blood is to transport oxygen from the lungs to all the cells of the body and move carbon dioxide in the return direction after it is produced by the cells' metabolism. Blood also carries nutrients to the cells and brings waste products to the liver and kidneys. Measured levels of oxygen, nutrients, waste, and electrolytes in blood are often used for clinical assessment of human health. Raman spectroscopy is a nondestructive analytical technique that uses the inelastic scattering of light to provide information on chemical composition, and hence has a potential role in this clinical assessment process. Raman spectroscopic probing of blood components and of whole blood has been on-going for more than four decades and has proven useful in applications ranging from the understanding of hemoglobin oxygenation, to the discrimination of cancerous cells from healthy lymphocytes, and the forensic investigation of crime scenes. In this paper, we review the literature in the field, collate the published Raman spectroscopy studies of erythrocytes, leucocytes, platelets, plasma, and whole blood, and attempt to draw general conclusions on the state of the field.
Introduction
On 10 December 1930, C.V. Raman collected the Nobel Prize in Physics for his work ''. . . on the scattering of light and for the discovery of the effect named after him.'' That same day, and at the same Stockholm ceremony (unusually), Hans Fischer collected the Nobel Prize in Chemistry for ''. . . researches into the constitution of haemin and chlorophyll and especially for his synthesis of haemin'' and another scientist, Karl Landsteiner, received the Nobel Prize in Physiology/Medicine for the ''. . . discovery of human blood groups.'' In the decades since Raman, Fischer, and Landsteiner were awarded their Nobel prizes, Raman spectroscopy has become an established analytical technique, and blood collection, blood transfusion, and blood research have become global enterprises involving many thousands of scientists and clinicians.
Blood is a vital bodily fluid responsible for numerous physiological functions. It comprises a yellow liquid medium called plasma in which a large number of cells, namely red blood cells (RBCs, also called erythrocytes), white blood cells (WBCs, also called leucocytes) and platelets (also called thrombocytes), are suspended. Simplistically, RBCs transport oxygen and carbon dioxide between cells and the lungs, WBCs fight disease and infection as part of the immune system, and platelets are vital for blood clotting and wound healing. The extracellular plasma also transports various proteins, electrolytes, and clotting factors, and changes in blood chemistry can be used to help assess the health status of patients.
Numerous diseases, such as diabetes, malaria, sickle-cell disease, and even particular types of cancers, can be characterized by distinct biochemical changes to the composition of blood. For example, an increase in the concentration of a protein called troponin is a very specific and sensitive indicator of heart muscle damage such as that which takes place during a myocardial infarction (heart attack). 1 Proper diagnosis of these health problems most often requires the application of analytical techniques that can be time-consuming and invasive to a patient. As a result, researchers have used Raman spectroscopy to help characterize blood and its cellular components. Having the means to measure the status of whole blood, as well as its individual components, in a rapid and non-invasive manner would provide clinicians with a diagnostic tool for disease detection and treatment.
The application of Raman spectroscopy for bloodrelated investigations began in the early 1970s with studies on the structure of hemoglobin, and further applications developed along with the improvements and innovations in Raman spectroscopy instruments and techniques. This review will describe the utility of Raman spectroscopy for the evaluation of blood-components and whole blood. Each of the five sections (Hemoglobin and Red Blood Cells, White Blood Cells, Platelets, Plasma and Serum, and Whole Blood) comprises a chronological overview of the published research in that area. For the most part, research that did not directly utilize blood from a human or an animal (i.e., an analyte mixed with a single component of plasma, such as the globular protein albumin) was excluded from the review. The paper concludes with a brief discussion of the direction of the field, as well as some limitations of the Raman spectroscopic analyses.
Instrumentation
Raman spectroscopy is a class of analytical techniques based on the collection and analysis of inelastically scattered light that contains information about the vibrational modes of a sample's constituent molecules. Different variants of Raman spectroscopy have been applied to the study of blood, and each has its own advantages and disadvantages.
Conventional Raman Spectroscopy/Microspectroscopy
As it pertains to the field of blood research, the preferred instrumental set-up for conventional Raman spectroscopy (also referred to as spontaneous Raman spectroscopy) 2 involves the coupling of a Raman spectrometer to an optical microscope. This set-up is capable of creating high spatial resolution, and individual blood cells have been interrogated using a laser trapping technique (the focusing of a laser beam creates a gradient force strong enough to trap dielectric objects, such as blood cells, with only a few milliwatts of laser power).
The advantages of Raman spectroscopy are its ability to interrogate samples rapidly, nondestructively, and with negligible interference from water (i.e., sample preparation is minimal). However, the biochemical components that are of interest when it comes to blood (proteins, nucleic acids, lipids, and carbohydrates, among others) exist in low concentrations and, because the Raman effect is weak, the intensity of the signal can be too low to be useful. Furthermore, many molecular components can generate substantial fluorescence signals that drown out the Raman photons. Raman spectroscopy studies involving blood often involve variants capable of providing Raman-intensity enhancements.
Enhanced Raman Spectroscopies
Resonance Raman spectroscopy (RRS) involves the use of laser excitation light whose energy coincides with an electronic transition in the target molecule. This approach improves the scattering cross-section and selectively enhances (by orders of magnitude) certain spectral features. 3 The resonance wavelength depends on the analyte of interest; for example, excitation at $400 nm coincides with a resonant enhancement of the Soret band of hemoglobin (the major constituent of RBCs). Resonance Raman spectroscopy has previously been reviewed elsewhere. 3 Another common type of Raman spectroscopy enhancement is surface-enhanced Raman spectroscopy (SERS), which was first reported in the 1970s. 4, 5 Surface-enhanced Raman spectroscopy functions to enhance Raman scattering using metallic surfaces or nanoparticles with plasmonic resonance characteristics. There are reports of effective Raman cross-sections being increased by up to 14 or 15 orders of magnitude, and the technique can be performed either directly (''labelfree'', where observed bands are associated with analytes themselves) or indirectly (characteristic spectrum of the SERS label changes in the presence of analyte). The field of SERS has grown rapidly since the late 1990s and has recently been reviewed. 6 Tip-enhanced Raman spectroscopy (TERS) 7 is a variant of SERS where the Raman enhancement occurs at the tip of a near-atomically sharp stylus (typically coated with gold). Tip-enhanced Raman spectroscopy combines the high chemical sensitivity of SERS with the spatial resolution of scanning probe microscopy, and it facilitates the study of individual molecules with sub-nanometer spatial resolution. A more recently adapted variant, surface-enhanced spatially offset Raman spectroscopy (SESORS), 8 combines SERS with spatially offset Raman spectroscopy (SORS). It involves the implantation of a metallic substrate into a sample and allows chemical information to be retrieved through a covering layer (e.g., skin).
Applications
Hemoglobin and Red Blood Cells Isolated Hemoglobin. Hemoglobin makes up >95% of the dried weight of RBCs and is a very strong Raman scatterer due to its highly conjugated heme sub-units. Thus, the Raman spectra of both RBCs and whole blood are dominated by hemoglobin bands (Table 1) , and hemoglobin spectra were the subject of much of the early work in the field. From mid-1972, groups from Princeton, NJ, USA (Spiro and co-workers) and Munich, Germany (Brunner and co-workers) began publishing RRS studies of hemoglobin. 9 Strekas and Spiro reported the first measurements (568.2 nm excitation) 10 from dilute aqueous solutions of hemoglobin derivatives, and the following month Brunner et al.
presented similar Raman results (488 nm excitation) from dilute hemoglobin solutions. In the latter work it was shown that the spectra of oxygenated hemoglobin (oxyHb) and deoxygenated hemoglobin (deoxyHb) differed markedly and that bands at 1220 cm À1 and 1360 cm À1 shifted upon transition from oxyHb to deoxyHb. It was therefore inferred that these modes were dependent on the displacement between the iron atom and the porphyrin group within the heme structure. 11 Follow-up work from the Princeton researchers demonstrated that the hemoglobin spectrum was polarization-dependent ( Figure 1 ) and confirmed Albrecht's vibronic theory of on-resonance Raman spectroscopy. 12 (Albrecht had theorized that onresonance Raman spectroscopy had different selection and polarization rules to off-resonance Raman spectroscopy.)
Later, Brunner and Sussner published a deeper investigation of the oxygenation states of hemoglobin and made the following observations.
Nearly all Raman lines of deoxyHb were approximately
twice as strong as those of oxyHb. 2. Three lines at 670, 1376, and 1468 cm À1 showed an absolute increase upon deoxygenation. 3. Three Raman lines of oxyHb (at 572, 1504, and 1636 cm À1 ) were completely missing in the spectrum of deoxyHb. 4. The line at 1223 cm À1 in oxyHb shifted to 1210 cm À1 upon deoxygenation. 5. The most conspicuous change was the frequency shift of the strongest line at 1376 cm À1 in oxyHb to 1355 cm À1 in deoxyHb. 
Amide I Figure 1 . Resonance Raman spectra of oxyHb as reported in 1972. The scattering geometry is shown schematically at the top of the diagram. Both the direction and the polarization vector of the incident laser radiation are perpendicular to the scattering direction. The scattered radiation is analyzed into components perpendicular (I r ) and parallel (I k ) to the incident polarization vector. The exciting wavelength was 568.2 nm and concentrations $0.5 mM. Reprinted from Spiro and Strekas. 12 Reproduced with permission from ß1972 National Academy of Sciences.
From this information, Brunner and Sussner deduced that the majority of Raman lines arise from vibrational modes involving the C-C, C¼C, and C-N bonds in the porphyrin conjugated ring structure. 17 In follow-up work, Brunner used an oxygen isotope to identify a mode assignable to stretching of the iron-oxygen (Fe-O 2 ) bond at 567 cm À1 (Figure 2 ). 18 Understanding the nature of the Fe-O 2 bond was thought to be vital to the elucidation of oxygen binding in hemoglobin, and it became the subject of much research. In 1973, Yamamoto et al. studied different forms of hemoglobin protein with RRS (441.6 nm excitation) to deduce the nature of the Fe-O 2 bond in oxyHb. Their results showed that iron in oxygenated hemoglobin exists in the low-spin ferric (Fe 3þ ) state rather than the low-spin ferrous (Fe 2þ ) state. 19 The following year, Spiro and Strekas published important work on the spin state of the central iron atom, 20 and Woodruff and Spiro later published a report that described a sample cell that allowed different forms of hemoglobin to circulate while spectra were being collected (thereby reducing absorption and photo-damage). 21 Similar work continued into the early 1980s, as the Spiro group 22,23 and others [24] [25] [26] [27] [28] explored the strength of Fe-O 2 bonds in ligated hemoglobin-like molecules. Throughout the rest of the decade, RRS 29 and SERS [30] [31] [32] were deployed to study these different forms of hemoglobin, and both the spectral and denaturation properties of these systems were thoroughly characterized. At the end of the 1980s, the Spiro group investigated the dynamics of ligand-binding to hemoglobin, using time-resolved UV resonance Raman (229 nm excitation). The study, which looked at carbonmonoxy-hemoglobin, found the transition time from the relaxed state (oxygenated, R) to the tense state (deoxygenated, T) to be $20 ms. 33 Raman spectroscopy studies of isolated hemoglobin continued into the 1990s. Ozaki et al. deployed near-infrared (NIR) Fourier transform (FT) Raman spectroscopy (1064 nm excitation) to study met-hemoglobin (metHb), a form of hemoglobin that contains iron in the Fe 3þ state but cannot bind oxygen. 34 Later, the Spiro group chemically altered sub-unit regions of hemoglobin that they suspected to be important to the protein's quaternary structure (they removed C-terminus residues from particular amino acids) and used two different RRS excitations (229 nm and 441.6 nm) to show the alterations increased hemoglobin's oxygen affinity and affected its functionality (the alterations reduced the protein's Bohr effect and its cooperativity). 35 Raman spectroscopy analyses of isolated hemoglobin and its many variants 36 have led to deeper understanding of the metalloprotein's form and function. The oxygenation of hemoglobin has continued to be of interest, and enhancement Raman spectroscopy techniques other than RRS have been applied. Coherent anti-Stokes Raman scattering (CARS) acquired quantitative measurements of oxygen saturation that agreed well with optical absorption analyses, 37 and one of the most highly cited hemoglobin studies was a SERS experiment that obtained spectra from single hemoglobin molecules attached to 100 nm sized immobilized silver particles. 38 
Raman Spectroscopy Studies of Intact Red Blood Cells
Intracellular Hemoglobin. In one of the early Brunner and Sussner studies mentioned above, 17 the investigators compared the spectrum of hemoglobin to the spectrum of intact RBCs and stated that ''the recorded Raman spectra of erythrocytes were identical to that of oxy-and deoxyHb, respectively, when we used the original suspension or added a small amount of deoxygenating dithionite''. 17 In 2001, almost thirty years after the original report, workers at Monash University in Victoria, Australia used conventional Raman spectroscopy (633 nm excitation) to record the same oxyHb (R state) and deoxyHb (T state) spectral features inside single living erythrocytes. 39 Figure 2 . Resonance Raman spectra of hemoglobin, Hb-16 O 2 and Hb-18 O 2 at 15 C, pH 7.4, 488 nm excitation. The band at 567 cm À1 appeared when hemoglobin was oxygenated, and shifted when oxygenated with an isotope. This mode was assigned to Fe-O 2 stretching. Reprinted from Brunner. 18 Reproduced with permission ß1974 from Springer-Verlag.
The group expanded their efforts in 2002 to include various excitation sources (488 nm, 514 nm, 568 nm, in addition to 633 nm), revealing differences in the spectra ( Figure 3 ) that could only be attributed to enhancement mechanisms associated with pre-resonance of the Soret band ($400 nm) and resonance around the Q bands (525-575 nm). 16 Excitation wavelengths between 400-500 nm were shown to enhance the totally symmetric A 1g modes while excitation between 500-600 nm enhanced the anomalously polarized A 2g modes and depolarized non-totally symmetric B 1g and B 2g modes. 40 In the years that followed, the Monash workers 15, 41 and others 42, 43 went on to characterize the cellular oxygenation/deoxygenation cycle; they would publish evidence of heme ordering within functional RBCs, 44 report insights related to intracellular heme-aggregation and denaturation, 45 investigate the effects of fixation and dehydration on the heme environment of hemoglobin, 46, 47 and use TERS to probe nanoscale oxidation changes on the surfaces of hemoglobin crystals. 48 This body of work significantly shifted the boundaries of hemoglobin research with conventional Raman spectroscopy from the isolated protein (i.e., model systems using commercial lyophilized protein) to the intracellular protein (i.e., examination of hemoglobin in real and living systems).
Recent measurements have shown that two different types of hemoglobin molecule can be resolved inside an intact living erythrocyte (sub-membrane hemoglobin and cytosolic hemoglobin) 49 and that SERS can be used to investigate oxy-and met-RBCs (the SERS spectra show characteristic heme bands, but also exhibit other prominent bands that may have been associated with cell membrane components and/or protein denaturation). 50 One of the co-authors of the latter study (McNaughton) was a member of the Monash group who were responsible for much of the earlier work on the oxygenation/deoxygenation cycle. The following year he was involved in another SERS study that characterized the interaction between nanoparticles and hemoglobin/RBCs, 51 and the year after that he co-authored work on hemoglobin's non-fundamental Raman modes; 52 enhanced overtones were observed in spectra of RBCs that, interestingly, were not found in hemoglobin solutions. McNaughton and another member of the Monash group (Wood) would go on to publish many Raman spectroscopy studies of pathology in erythrocytes, which are discussed in the relevant section below.
In 2015, Raman spectroscopy (488 nm excitation) was combined with atomic force microscopy (AFM) to image single RBCs from smears of dried whole blood, and internal distributions of Fe 2þ /Fe 3þ hemes were shown for the first time. 53 The oxidation state of iron is crucial to proper hemoglobin functionality, and Raman spectroscopy imaging of the smears showed the existence of hemichrome (a nonfunctional form of Fe 3þ hemoglobin) on the periphery of RBCs, while the internal part of the cell existed in an oxyHb state after dying.
Laser Tweezers Raman Spectroscopy (LTRS) Studies of
Hemoglobin and RBCs. In the early 2000s optical tweezers (instruments that capture, hold, and perform very fine mechanical manipulations on small particles) were combined with Raman spectroscopy to create a new class of scientific instrument. The new ''laser tweezers Raman spectroscopy'' (LTRS) instruments could be used to collect chemically specific information from cells, bacteria, and viruses. The technique allowed much more detailed investigations of hemoglobin, and many of the early demonstrations of LTRS were performed using RBCs as samples. [54] [55] [56] [57] As LTRS technology has matured, it has been used to refine previous studies that had experienced limitations due to sampling protocols. Dasgupta et al. used LTRS to examine the laser-induced degradation of hemoglobin inside trapped erythrocytes, and the results demonstrated increased intensities of the 975 cm À1 , 1244 cm À1 , and 1366 cm À1 Raman bands ''after exposure to 7 mW of NIR light for a few tens of seconds''. 58 These bands were consistent with hemoglobin existing in an aggregated form, confirming earlier work by researchers from the Monash Figure 3 . Raman spectra of oxygenated single erythrocytes recorded using different excitation wavelengths. The spectra presented are averaged from four spectra recorded of different erythrocytes under the same conditions. Reprinted from Wood and McNaughton. 16 Reproduced with permission ß2002 from John Wiley & Sons, Inc. group. Ahlawat et al. then used LTRS to examine the ordering of hemoglobin inside the cell. They observed that particular intensities were dependent on orientation, with the most prominent intensity change occurring in the band at 754 cm À1 (pyrrole breathing vibration). The results of theoretical simulations suggested that hemoglobin ''must be present in an ordered arrangement, such that the hemeporphyrin planes are preferentially orientated parallel to the RBCs' equatorial plane''. 59 Laser tweezers Raman spectroscopy has become an increasingly important technique in the study of living RBCs, for investigations of oxygenation within single cells, [60] [61] [62] and for investigation of the effects of laser light on RBC biology. [63] [64] [65] The method has also been integral for characterizing red cell response to stimulus/ stress (e.g., alcohol-induced denaturation, 66 electrical current, 67 oxidative stress, 68 and pH changes 69 ), and has been deployed to compare oxygen uptake of different globin-containing cells. 70 Workers at the Center for Biophotonics, Science and Technology, UC Davis, who contributed to developing the LTRS capability, have studied a number of these phenomena. [71] [72] [73] Red Blood Cell Membrane. As some investigators were elucidating the form and function of RBC hemoglobin, other groups were characterizing RBC membranes. In 1972, Bulkin reported a Raman spectroscopic study (632.8 nm excitation) of human erythrocyte membranes. The spectra of the isolated membranes (called ''ghost cells'' due to the removal of all internal components) showed bands at 1110 cm À1 , 1340 cm À1 , 1420 cm À1 , and 1445 cm À1 that were attributed to ''the hydrocarbon chains of the fatty acids, with a possible small contribution from the CH 2 groups of cholesterol''. 74 In the mid-1970s, Raman spectroscopy was used to study the protein components of RBC ghosts; the results suggested that the protein fraction contained 40-55% a-helix with little b-configuration and that 55-65% of the hydrophobic side chain content of the phospholipid were in the ''all-trans rigid'' configuration. All Raman modes were ''assigned to either protein or phospholipid'' at 488 nm excitation, with no suspected contribution from cholesterol. 75 Verma and Wallach shed more light on the ''ghost cell'' system over the following years. They identified two strong bands attributable to conjugated double bond systems 76 (later shown to be carotenoids 77 ), studied the effects of transmembrane ion gradients, 78 and investigated the sensitivity of temperature/pH to membrane-state transitions in the CH-stretching region. 79, 80 During the same period, other workers discovered specific vibrations related to membrane fluidity, peptide-backbone conformation, and disulfide bonding. 81 The 1970s also saw Raman spectroscopy studies (514.5 nm excitation) of intact erythrocyte membranes and of membranes from which the peripheral proteins had been extracted. The results indicated that the extraction caused considerable changes in the peptide bonds but had little effect on lipids, and that the secondary structure of the remaining intrinsic membrane proteins was modified. 82 Decades later, the same group published work on the relative lipid and protein contributions to the amide I band (using 488 nm excitation). 83, 84 More recently, Li et al. used Raman (785 nm excitation) and chemometric analyses to show that 30 minutes of exposure to mid-ultraviolet (UVB) radiation could damage RBC membranes. The data showed a decrease in the amount of a-helix and side-chains (CH 2 /CH 3 ) while the random coil conformation content increased. 85 Red Blood Cell Biology. While Raman spectroscopy research into particular RBC components has continued, investigations of whole-cell erythrocyte biology have also been reported. Raman spectroscopy has been used, for example, to study the mechanisms associated with RBC ageing. 86, 87 In these studies, cells were separated by Percoll fractionation (where the lightest 25% were said to be the youngest and the heaviest/densest RBCs were said to be the oldest) and subjected to line mapping analysis (514.2 nm excitation). The intensity of the 1358 cm À1 band (assigned in a previous work to the symmetric half-ring stretch of pyrrole) across the samples suggested that hemoglobin was less uniformly distributed in older RBCs. The authors stated that, in the older cells, hemoglobin molecules ''are aggregated and attached to the inside cell membrane'' which reduced membrane flexibility and possibly influenced hemoglobin's oxygenation. The authors also suggested that when hemoglobin is bound to the inside of the membrane, ''the reactive oxygen species generated in autoxidation are not efficiently neutralized by the cellular antioxidant enzymes''. 87 A more recent (2014) study used another variant of Raman spectroscopy (2D Raman correlation spectroscopy) to investigate age-related disintegration of RBCs. The asynchronous spectra in the data set (which represent the overall differences in the time behavior) led the authors to suggest that the heme groups separate themselves from the globin proteins, and the synchronous spectra (which represent the similarities in the time behavior) suggested that the globin proteins break down into individual amino acids. The data also pointed towards metal ion centers being involved in the disintegration process. 88 Red Blood Cell Transfusion. Blood banking agencies obtain whole blood from volunteer donors, separate the RBCs by differential centrifugation, suspend them in specially formulated additive solutions such as saline-adenine-glucosemannitol (SAG-M), and store them in polyvinyl chloride (PVC) blood-bags at 4 C until they are needed for transfusion. Despite extensive efforts to maintain RBC viability and function, RBCs degenerate and disintegrate during storage. Raman spectroscopy is one of the techniques that has been deployed to elucidate the storage-related changes, 89 Figure 4 ). The work hinted at correlations between lactate release and specific donor characteristics, such as gender and age. 90 The possibility of performing non-invasive Raman spectroscopy investigations of the RBC storage lesion in situ, inside the standard PVC blood-bags, has recently been raised by Buckley et al. 91 Hemoglobin, Red Blood Cells, and Disease. There have been many Raman spectroscopy and LTRS studies of pathological hemoglobin and RBCs in recent years.
Malaria. Malaria is caused by a genus of parasites called
Plasmodium and is transmitted via the bites of infected mosquitoes. The parasites multiply in the liver of the human body and then infect RBCs where they catabolize hemoglobin and produce a waste-product called hemozoin. Each year, more than 1 million of the 300-500 million people infected with malaria die. The current gold standard for malaria diagnosis is the microscopic examination of Giemsa-stained blood smears, a process that is time-consuming and requires trained operators.
Since the 1990s, researchers have been investigating the possibility of using Raman spectroscopy as an alternative diagnostic tool for malaria. Brémard et al. used RRS to characterize hemozoin 92 and Ong et al. used RRS to characterize infected RBCs. 93, 94 It was mentioned above (Intracellular hemoglobin) that workers at Monash University carried out some of the earliest studies of intracellular hemoglobin 16, 39, 41 and that, in the years since, two members of the team, Wood and McNaughton, have gone on to do much Raman spectroscopic analysis of pathological erythrocytes. In 2003, Wood, McNaughton, and co-workers reported an enhancement of a particular hemozoin Raman band (at 1374 cm À1 ) that allowed the food vacuole of a Plasmodium-infected cell to be imaged ( Figure 5 ). 95 The following year, they reported a more detailed Raman spectroscopic study of hematin (the synthetic analog of hemozoin). 96 In 2007 the Monash workers co-authored a study in which acoustic levitation was used to suspend RBCs and Plasmodium-infected cells in place, allowing the measurement of the spectral signature of hemozoin in the diseased cells. 97 One of the co-authors of that study, J. Popp, had previously been one of the early workers on LTRS. 98 Popp and his colleagues would go on to investigate hemozoin morphology with visible light (633 nm and 647 nm) 99 and later introduced a fiber-array based instrument capable of selectively analyzing hemozoin in the early stages of malarial infection. 100 Popp would co-author many Raman spectroscopic studies on other types of blood cells, and these are described in the appropriate sections below.
In 2009 the Monash group combined RRS with partial dark-field microscopy to detect and diagnose malarial signatures in thick blood films. 101 Other groups would go on to use Raman spectroscopy to elucidate hemozoin formation inside malaria-infected erythrocytes; for example, RRS would be coupled with chemometric analysis to map the spatial distribution of heme species inside the cells, 102 and LTRS would be used to compare healthy RBCs with cells that were infected with Plasmodium vivax. 103 In the latter study, spectral changes occurred in bands associated with heme oxygenation, suggesting that a significant fraction of intracellular hemoglobin in the infected cells had a reduced oxygen affinity. 103 After it had been shown that hemozoin could be measured with Raman spectroscopy, pharmaceutical research avenues, such as monitoring interactions between hemozoin and drug candidates, became a reality. Wood, McNaughton, and co-workers were the first to study the effect of anti-malarial drugs on the hemozoin spectral signatures. In one study, infected cells were incubated with the most commonly used drug, chloroquine, and structural changes in hemozoin were detected with Raman spectroscopy as several bands became less intense in comparison to control cells. 104 In another study, they demonstrated that TERS could potentially be used to analyze drugs binding to the hemozoin surface inside the digestive vacuole of Plasmodium cells. 105 The TERS spectrum showed a similar hemozoin spectral profile to RRS in terms of band position, although the relative enhancement of bands was somewhat different and band shifts were observed.
Much of the recent work in the field has been devoted to achieving real-time diagnosis. In 2013, conventional Raman spectroscopy (532 nm excitation) was used to monitor the progression of malaria in mice. The spectral changes in erythrocytes and plasma were followed over the course of seven days of infection. Heme-related changes were detected in the very early stages (as little as one day after Plasmodium infection) and this was meaningful because existing techniques can struggle in these stages where the parasitemia levels are low (on the order of 0.2%). Further principal component analysis (PCA) indicated erythrocyte membrane changes at day 4, when parasitemia levels reached 3%. 106 Detection of hemozoin has also been attempted with SERS in two ways: mixing silver nanoparticles with lysed blood for a SERS analysis, and synthesizing the silver nanoparticles directly inside the parasites. Using the first method the lowest detectable parasitemia level was reported as 0.01%, and with the second method the detection limit was said to be as low as 0.00005% (approximately 2.5 parasites/mL of blood). 107 Genetic Blood Disorders. Two genetic blood disorders, thalassemia and sickle-cell disease (SCD), have been investigated with Raman spectroscopy. Thalassemia is characterized by abnormal formation of hemoglobin and improper oxygen transport. Laser tweezers Raman spectroscopy has been used to probe thalassemic RBCs, and it has been found that both the spectroscopic and mechanical properties of the cells are different in comparison to normal controls. 108 Sickle-cell disease results from a point mutation in a codon of the globin gene (a glutamic acid is replaced by valine). It causes RBCs to assume an abnormal, rigid, sickle-like shape and is associated with a number of acute and chronic health problems, such as severe infections, attacks of severe pain, or stroke. The researchers from Monash University (mentioned above) investigated sickle cells and determined that their Raman spectra resembled a normal deoxyHb red cell, but with exaggerated features attributed to hemoglobin aggregation. They were able to image the 1248 cm À1 band, a prominent feature of aggregation, and visualize the aggregated hemes within the sickled cell. 40 In 2012, the UC Davis group (also mentioned above) used sickle cells as demonstration samples in one of the early reports of LTRS, 72 and they later used the technique to show that sickle cells deoxygenated more readily under (optical or mechanical) stress than healthy control cells. 73 Recently, Raman spectroscopy has been proposed as a tool for quick and accurate diagnosis of SCD, and a clinical investigation has been performed by researchers from Brazil. The results showed that subtle changes in the polypeptide chain of abnormal hemoglobin could be discerned from the normal hemoglobin variant, and that the chemometric model designed by the group correctly discriminated 100% of the samples in each cell class. 109 Other Diseases and Disorders. Raman spectroscopic investigations of hemoglobin and RBCs have also been undertaken by researchers for other (non-blood) diseases. A 1988 study compared RBCs collected from seven people suffering from rheumatoid arthritis with seven controls and used Raman spectroscopy to measure the rapidity of the hemoglobin oxygenation. The cells from veins of those with rheumatoid arthritis were said to be more oxygenated initially, but remarkably showed a (statistically significant) tendency to take up atmospheric oxygen more slowly. 110 The authors stated that (a) and (b) strongly suggest oxyhemoglobin content was diminished in heart failure, and that (c) contributed to the reduced O 2 tissue supply seen in patients with heart failure. 111 Raman spectroscopy of RBC components has also been proposed as a new method for diabetes diagnosis. The envisaged test would be based on the correlation of in vivo hemoglobin glycosylation with the average concentration of glucose in blood plasma. It was shown in 2010 that SERS could be used to detect glycated hemoglobin (HbA 1c ) at very low concentrations 112 and, in 2014, drop-coating deposition Raman spectroscopy was deployed for the same task. 113 In the same year Lin et al. demonstrated that damaged membrane lipids (e.g., decreased liquidity and altered phospholipid organization) could be detected using Raman spectroscopy in RBCs collected from diabetic patients. With the aid of multivariate statistical methods (and analysis of the high-wavenumber region of the spectrum), they achieved a diagnostic accuracy of 98.8% for differentiating diabetic from normal RBC membranes. 114 Finally, recent Raman spectroscopy studies have investigated heme proteins from the blood of children with epilepsy, 115 and metHb has been measured as a clinical biomarker of pathophysiology, such as in nitrite poisoning. 116, 117 White Blood Cells White blood cells are part of the body's immune system, and are responsible for fighting bacterial, viral, and fungal infections. There are three main types of WBCs-monocytes, lymphocytes, and granulocytes-and together they account for approximately 1% of blood cells. Raman spectroscopic analyses of WBCs began in the early 1990s, and many of the early studies were published by Puppels et al. at the University of Twente. They showed that Raman spectroscopy could be used to distinguish the WBC nucleus from the cytoplasm ( Figure 6 ), 118 that cytoplasm spectra could be used to distinguish different subtypes of WBCs, 119 and that carotenoids (an important class of anti-oxidants) were present in high concentrations at distinct sites in the cytoplasm of specific cell populations. 120 Another early Raman spectroscopic study of WBCs used RRS to detect cytochrome b558, an enzyme thought to aid the generation of reactive-oxygen species for phagocytosis, in frozen pellets of neutrophilic granulocytes. 121 In the 1990s, WBCs were the subject of further Raman spectroscopic analysis by other groups. It was reported that the level of carotenoids in one type of lymphocyte decreased with donor age, 122 that both reduced and oxidized forms of important enzymes cytochrome b558 and myeloperoxidase (MPO) could be distinguished, 123 and that these important enzymes could be elucidated using Raman spectroscopy (the redox state of both cytochrome b558 and MPO were changed upon cell activation, which demonstrated that processes inside living neutrophils could be monitored using Raman spectroscopy). 124, 125 Raman spectroscopic studies of WBCs continued through the first decade of the 2000s and new technologies such as Raman mapping 126 and LTRS 127 were utilized. It was mentioned above that J. Popp and his colleagues at Jena University combined Raman techniques with statistical analyses (hierarchical cluster analysis, PCA, support vector machines, etc.) to rapidly identify various types of blood cells in various body fluids; in 2003, they used fluorescence labeling combined with Raman microspectroscopy to distinguish subtypes of WBCs found in cerebrospinal fluid (interference was avoided by ''using an appropriate fluorescence dye and a Raman excitation wavelength [532 nm excitation] far away from the absorption region of the dye''). 128 The group then developed a Raman cell-classifier to create a protocol that would be capable of identifying the two most abundant WBCs (the neutrophilic granulocyte and the mononuclear lymphocyte) from one another. This process, which is illustrated in Figure 7 , used Raman imaging to visualize morphological features, and achieved an accuracy of 94% in the validation step. It was able to predict the identity of unknown cells from a completely different donor with an accuracy of 81% using a single spectrum. 129 The group at Jena are not the only ones continuing Raman spectroscopic studies on WBCs. In 2011, Pully et al. used time-lapse Raman imaging to demonstrate that carotenoids, lipids, and RNA could be tracked in the cytoplasm of live lymphocytes. Using difference spectra ( Figure 8 ) they also revealed photo-induced changes to carotenoid molecules. 130 Cancer and Disease. Most Raman spectroscopic studies of diseased WBCs have focused on the discrimination of diseased and healthy cells rather than on the underlying pathology. The earliest work by Schmidt-Ullrich et al. in 1975 used isoelectric focusing and Raman spectroscopy (488 nm excitation) to compare cell membranes that had been isolated from normal hamster lymphocytes and cell membranes that had been isolated from lymphoid cells (cells lacking granules that had been transformed by the DNA virus SV40). The study showed that membranes of transformed lymphocytes differed from those of normal cells: several defined bands appeared, and two shoulders were replaced by defined bands, with the general explanation that a greater proportion of aspartate-glutamate residues were amidated in the membranes of the transformed cells. 131 More recently, Popp et al. demonstrated that Raman microspectroscopy (785 nm excitation) could be used to characterize WBCs, leukemic cells, and solid tumor cells that were found in peripheral blood and dried on a slide. 132 Aspects of this research were repeated using aqueous suspensions of the cells and produced comparable results. 133 The same group has gone on to combine optical traps (in microfluidic environments) and Raman microspectroscopy to improve their classification of peripheral blood cells. 134 Figure 9 shows Raman spectroscopy results (514 nm excitation) from a dedicated microfluidic glass chip that incorporated functionalities ''to separate cells from a reservoir, trap single cells, and sort them according to the Raman- based classification''. The results showed that 77 out of 80 OCI-AML3 cells (96.3%), 83 out of 87 MCF-7 cells (95.4%), 25 out of 29 leucocytes (86.2%), and 75 out of 78 BT-20 cells were correctly classified. Similar discrimination was also achieved in 2011, when a group from Emory University used SERS nanoparticles to probe cells obtained from the blood of 19 patients diagnosed with cancer of the head and neck. The spectral analysis was able to differentiate between circulating tumor cells and WBCs with high sensitivity, even though the host blood cells outnumbered cancer cells ''by 5 to 6 orders of magnitude''. 135 In the RBC sections above, workers at UC Davis were mentioned in relation to LTRS studies of RBCs. This group (Chan et al.) has also reported LTRS studies that compared normal and diseased WBCs. In 2006, they were able to discriminate between unfixed normal human lymphocytes and lymphocytes from cultured cell lines (Jurkat and Raji) that were transformed to model leukemia cells. The spectral differences were highly reproducible for each neoplastic cell type with characteristic changes in the peaks associated with DNA and proteins. 136 The study was reproduced later using actual cells from clinical patients, and ''the results indicated that, on average, 95% of the normal cells and 90% of the patient cells were accurately classified into their respective cell types.'' 137 Chan et al. have also used LTRS to measure the effect that doxorubicin, a common chemotherapy drug, had on leukemic lymphocytes at different time points over 72 h exposure. 138 The observed changes in the Raman spectra were dependent on drug exposure time (sampling time-points at 24, 48, and 72 h) and concentration (0.1 mm and 0.5 mm of continuous doxorubicin exposure). The spectral changes included intensity changes in lipid Raman peaks, in DNA Raman peaks, and in phenylalanine peaks. They concluded that these features were consistent with various biochemical responses that were expected to occur during the different stages of drug-induced apoptosis. This Figure 9 . Mean Raman spectra of WBCs compared to various leukemia (OCI-AML3) and tumor (BT-20, MCF-7) cell lines measured with a dedicated microfluidic glass chip. Spectra were background corrected and normalized, and the grey region were used in the statistical analysis by the authors. Reproduced from Dochow et al. 134 Reproduced with permission ß2011, The Royal Society of Chemistry. Figure 8 . Plot for the Raman difference spectroscopy results (647 nm excitation) for cell spectra (top) and variations in the carotenoid molecules. As the carotenoid cellular content decreases, the carotenoid bands increase in the difference spectra. Adapted from Pully et al. 130 Reproduced with permission ß2011, from John Wiley & Sons, Inc. study was later expanded and hyper-spectral Raman images (785 nm) of lymphocytes were obtained after exposure to doxorubicin with an extra time-point at 96 h. These results showed significant differences between the biochemical trends in local and global changes of the cells, which suggested that valuable information about the entire cell can be missed if only Raman spectra of localized cell regions are used. 139 
Platelets
Platelets are small anucleated cells that are central to blood coagulation, inflammation, wound-healing, angiogenesis (the development of new blood vessels), and other pathophysiological processes. The first Raman spectroscopic investigations of platelets and platelet structure were reported in the late 1970s when workers in France isolated platelets from whole blood, washed them, and put them in a continuous-flow system for Raman spectroscopic analysis (488 nm and 514.5 nm excitations). The spectra exhibited three prominent peaks that the authors assigned to vibrations of carotenoids, but they were unable to exclude the possibility that the pigments had not been internalized from plasma. 140 Shortly thereafter, the same research group analyzed the variation of the platelet membrane spectra at (eight) different temperatures. They claimed that heated platelet-membrane lipids underwent a double thermotropic-state transition, and that there may have been a link between the lipid transitions and the carotenoids. 141 For the following three decades the field stagnated and it was not until the mid-2000s that Okpalugo et al., motivated by an interest in films and biomaterials, used Raman spectroscopy and platelets to investigate ''the effect of changes in microstructure, surface energy, surface charge condition and electronic conduction on the interaction of human platelets with silicon modified hydrogenated amorphous carbon films''. 142 A few years later a group from the Guangxi Academy of Sciences in China used LTRS to collect Raman spectra (785 nm excitation) from platelets derived from different species (human, pig, rat, and rabbit). 143 Their published spectra are shown in Figure 10 .
Recently, Raman spectroscopy of platelets has become of interest to workers researching Alzheimer's Disease. In 2011, Chen et al. 144 isolated and analyzed (633 nm excitation) platelets from a mouse model of Alzheimer's disease and compared them to healthy controls; notable spectral differences were revealed in the 740 cm À1 band (protein side chain vibration) and the 1654 cm À1 band (amide I band of the protein a-helix structure). This research has since been expanded, as multi-layer perception 145 and an adaptive Gaussian process algorithm 146, 147 were used as strategies for classifying suspect platelets.
Plasma and Serum
As mentioned above, over 50% of the total volume of blood is plasma, a mildly alkaline aqueous fluid in which the cells are suspended. Plasma is mainly water but it also contains dissolved proteins (e.g., albumins, globulins, fibrinogen), clotting factors, and other metabolically relevant compounds (e.g., electrolytes, hormones, antibodies, etc.). When the fibrinogen and clotting factors are removed from plasma, the simplified liquid is called serum. Molecular analysis of blood plasma/serum can potentially offer insight into metabolic processes occurring in the body, and there is growing interest in using Raman Figure 10 . Mean Raman spectra of single platelets and tentative peak assignments (abbreviations: Phe, phenylalanine; Tyr, tyrosine; Trp, tryptophan; Pro, proline). Reprinted from Wang et al. 143 Reproduced with permission ß2007, Zhonngguo Guangpuxue Xuehui. spectroscopy to develop molecule-specific, accurate, and reusable plasma/serum sensors for diagnostic and monitoring purposes.
Screening for Metabolites and other Chemical Species. The earliest interrogation of blood plasma using Raman spectroscopy was performed by researchers from the University of Gö teborg in 1974. They discovered strong Raman scattering bands (514.5 nm excitation) in plasma from healthy patients at 1160 and 1520 cm À1 , and assigned the bands to resonance-enhanced conjugated systems of C-C single and double bond stretching vibrations. They also probed plasma from patients who had been diagnosed with medical conditions (various forms of bacterial, viral and fungal infections, and various forms of cancer) and found many of those spectra to have more intense fluorescence backgrounds than the healthy samples. 148 In 1976, researchers located in New Jersey, USA suggested that the Raman bands in plasma were associated with carotenoids (Figure 11 ), 149 and a decade later (488 nm excitation), the assignment was confirmed with a larger cohort of patients who had been diagnosed with a range of cancers (e.g., malignant tumors and also patients in remission). 150 The use of Raman spectroscopy to screen for metabolites was dormant for much of the next decade until technological developments brought the field back into focus. In the mid-1990s, Ozaki et al. attempted to address the problem of the fluorescence background from plasma by utilizing the chromatic aberration of a lens (514.5 nm excitation) to collect anti-Stokes Raman spectra. 151 This approach produced the same strong carotenoid bands as previously described, and, after adding glucose artificially to both plasma and serum, the researchers used the intensity of a band at 1135 cm À1 (due to the C-O stretching mode) to estimate glucose concentration. From this time onward, there has been a concerted effort by many groups to measure plasma metabolites at physiological concentrations.
In 1999, two groups investigated human sera from >60 individual donors to predict concentrations of relevant metabolites with the aid of a multivariate model. Qu et al. collected Raman spectra (785 nm excitation) to predict the analyte concentrations of total protein, albumin, triglyceride, and glucose, 152 and Berger et al. generated Raman spectra (830 nm excitation) to analyze concentrations of glucose, cholesterol, triglyceride, urea, total protein, and albumin (in both of these studies, experimenters removed macro proteins that masked subtle features in their analytes). 153 Researchers in Germany made the next advance when they measured the concentrations of eight analytes in serum from a pool of 247 donors. 154, 155 Qi and Berger later implemented a liquid-core optical fiber geometry (830 nm excitation) to enhance the Raman signal from serum and urine samples by one to two orders of magnitude. 156 Another study attempted to avoid the proteinremoval step by concentrating spots of the plasma as dried drops; they attempted to quantify fibrinogen and obtained results that were comparable to the traditional gold-standard fibrinogen assay. 157 The strong fluorescence interference and the inherently weak Raman signals from the lower-concentration components of plasma would always place limits on what could be achieved with conventional Raman spectroscopy, and in the 2000s research began a shift towards enhancement techniques. At the forefront of this work was the group of R. van Duyne at Northwestern University, who developed a glucose sensing platform that consisted of a functionalized SERS-active substrate (785 nm excitation). 158 Their preliminary experimental approach demonstrated the potential for quantitative glucose measurements in the presence of bovine serum using the 1462 cm À1 line. 159 The next step involved implanting their substrate inside a living animal and verifying if the platform could provide quantitative accuracy in vivo. 160 Using Sprague-Dawley rats and SESORS, they demonstrated that consistent, stable, and accurate Raman measurements of glucose could be performed when the probe was implanted and surrounded by interstitial fluid (rather than blood). The SESORS approach eliminated the need to remove the platform from the rat and allowed direct detection of glucose with high accuracy. 161 The great potential behind Raman spectroscopic sensing of glucose makes it an attractive target for scientific inquiry, but other metabolites have also been investigated.
In 2005, Stosch et al. applied SERS (514.5 nm excitation)
with silver colloids to quantitatively determine creatinine, an endogenous degradation product of muscle metabolism and a marker for proper kidney function, in human serum. The addition of pure unfiltered serum to the pre-aggregated silver colloid did not produce characteristic creatinine bands in the SERS spectrum due to interference from proteins. 162 
In 2008, Stokes et al. reported a SERS study of blood
serum spiked with folic acid. This vitamin is involved in many biosynthetic processes and is related to disease processes, such as certain birth defects, and the experiments showed the potential for quantitative Raman spectroscopic detection (514.5 nm excitation shown to be optimal). 163 
Widely used as an indicator of muscular tolerance
during exercise, lactic acid is difficult to detect at physiological concentrations with traditional Raman spectroscopy. 164 In 2009, Hsu and Chiang used silver nanoparticles for a SERS measurement to identify and quantify this metabolite at concentrations below physiological levels. Once again, interference from non-specific adsorption dominated unless pure human serum was used. 165 
4.
A protein native to blood plasma called C-Reactive protein (CRP) is used as a clinical biomarker of bacterial infection and tissue damage. When inflammation occurs, the concentration of CRP circulating in the blood rises. In 2009, researchers from the University of Southern Denmark acquired Raman spectra of CRP (785 nm excitation) and measured the concentration of CRP in blood plasma from 40 donors. 166 As is common in the complex plasma mixture, other proteins interfered with the ability of Raman spectroscopy to provide specificity for a particular component. In this study, however, the authors concluded that CRP could be differentiated from the varying plasma background with the assistance of a multivariate model. 5. Researchers in Boston, USA sought to characterize the Raman activity of human blood and its components. One key variable investigated in their experiment was the time dependence of their SERS spectra, and how this data compared with non-SERS spectra. Without the need to isolate or quantify a particular analyte, the researchers did not subject the plasma to filtration prior to analysis, but did allow time for the volume of the plasma drop (on the solid-SERS support) to decrease via evaporation. The results demonstrated that over a period of 24 h after sampling, the SERS spectrum of plasma became dominated by the signature of hypoxanthine, a well-known purine degradation product. 50 Despite the promising results obtained from SERS experiments on analytes in blood plasma, most were proof-of-principle and only demonstrated the possibility of detecting an analyte that was artificially spiked with the analyte. In 2014, a study on the shortcomings of SERS discussed the lack of published information on: (a) the effect of sample processing (e.g., filtration) and experimental parameters (e.g., excitation wavelength, metal colloid, etc.); (b) the comparison of serum with plasma; and (c) the spectral variability between individuals. They concluded that SERS spectra of both filtered serum and plasma were dominated by two highly variable metabolites, uric acid and hypoxanthine, and that the inherent problems with reproducibility had profound consequences for the field. 167 Cancer. A number of Raman studies have sought to identify, classify, and even quantify biomarkers that may provide information about various forms of cancer. In 2007, researchers based in Mexico investigated serum samples from 23 patients (11 diagnosed with breast cancer and 12 healthy controls) using Raman microspectroscopy (830 nm excitation) and multivariate statistical methods. 168 The Raman spectra of the diseased samples and healthy controls were similar but had slight peak shifts and differences in peak intensities; the researchers were able to identify seven ratios of band intensities that appeared to be significant, and they assigned these ratios to represent proteins, phospholipids, and polysaccharides. Scatter plots from their multivariate an\alysis, however, did not show a clear discrimination between diseased and healthy patients as the number of samples was too small. The same methodology was used later for other types of cancers, such as leukemia, 169 head and neck cancer, 170 and cervical cancer, 171 and the preliminary results were similar with a reported improvement in class discrimination as presented by a multivariate analysis.
In recent years, Murali Krishna et al. from the Chilakapati Laboratory in Mumbai, India have carried out a series of Raman studies using plasma for the investigation of cancer. In 2013, they obtained serum from 40 patients with tongue cancers and compared it with 16 healthy control samples. They observed differences in the bands associated with nucleic acids (the differences suggested an increased cell-free DNA presence) and a decrease in the amount of b-carotene for patients in the cancer group. 172 In 2015, they repeated the study using a larger subject cohort (328 donors, 785 nm excitation) and an added dimension of evaluating the serum for the detection of premalignant chemical conditions. 173 Another 2015 study from the group investigated the feasibility of discriminating between serum from patients suffering from malignant tumors who had endured a recurrence of their cancer post-surgery and serum from patients suffering from malignant tumors who had not. While the spectra reported negligible pre-surgery differences between serum from recurrence and nonrecurrence patients, the post-surgery spectra revealed measurable differences. These changes were attributed to DNA and variable protein content in the groups. 174 Researchers from Guangdon, China have carried out similar Raman work regarding cancer detection in plasma. They used the drop-coated deposition technique on plasma from patients with colorectal cancer (15 patients) and from normal healthy controls (21 volunteers). The Raman data (785 nm excitation) suggested an increased level of cell-free DNA and a decreased level of b-carotene in the cancer group, similar to that reported above. Two mechanisms have been proposed to explain these increased nucleic acid levels in cancer patients' blood (apoptosis/necrosis, or release of intact cells in the bloodstream and their subsequent lysis), while a diminished b-carotene was in agreement with previous reports, which suggested a deficiency of anti-oxidant species is an important risk factor for the progression of pre-cancer to cancer. 175 Many studies of plasma/serum samples from cancer patients have been performed using conventional Raman techniques but more recently SERS has also attracted much attention. In 2010, researchers from Fujian Normal University of Fuzhou, China published the first SERS analyses (785 nm excitation) of blood plasma for cancer detection. 176 Silver nanoparticles were directly mixed with blood plasma from 76 samples (43 samples came from patients with pathologically confirmed nasopharyngeal carcinomas and 33 from healthy volunteers) and the SERS spectra showed distinct variation between the two patient groups for a variety of bands, while PCA scores were compared to demonstrate the potential for discrimination. In the years that followed, the same group published more studies of nasopharyngeal cancer (NPC) 177 and numerous other SERS studies that took the same exploratory approach towards the detection of different types of cancers, including gastric cancer, [178] [179] [180] colorectal cancer, 181, 182 and cervical cancer. 183 Surface-enhanced Raman spectroscopy spectra obtained from the 2014 NPC study (Figure 12 ) demonstrated that different tumor (T) stages in NPC have distinct spectral differences. A repeated observation in all of their studies, regardless of the type of cancer, was that the SERS band at 725 cm À1 (assigned to the C-H bending mode of adenine) was higher in cancer serum than in normal serum, suggesting abnormal metabolism of DNA bases in the serum of cancer patients.
Another group of researchers from China, at Sichuan University in China, similarly used SERS (633 nm excitation) to discover that the intensities of peaks assigned to nucleic acids and proteins increased in the serum spectra of patients with parotid gland tumors compared to serum spectra from normal healthy controls. 184 Other Diseases. Raman spectroscopy has been used to probe plasma/serum samples from patients with various other types of disease. In 2006, Popp et al. used UV-RRS (244 nm excitation) to study the cryoprecipitated human plasma of patients with thrombotic microangiopathy, a pathology that results in thrombosis (formation of a clot inside a blood vessel). 185 At the selected wavelength, Raman signals of aromatic amino acids and proteins were selectively enhanced and the study demonstrated considerable variations in the intensities of bands at 1551, 1615, and 1650 cm -1 (associated with the amide II vibration, in-plane stretching vibrations of aromatic amino acids, and the amide I vibration, respectively). While classifying the two groups using hierarchical cluster analysis was possible, the contribution of lipoproteins to two of these bands raised questions about the effect of sample processing on the plasma as lipids should not have been present in the cryoprecipitated mixture. Almost a decade later, the same group tested Raman spectroscopy of dried plasma (785 nm excitation) as a method for discriminating between bacterial (sepsis) and non-bacterial inflammatory responses (samples from 70 individuals: 31 in the former group, 39 in the latter). 186 The average spectra from both populations appeared very similar, but when multivariate statistical methods were applied the patient data could be separated, and the authors concluded that there was a high potential to distinguish these populations.
Raman spectroscopy of plasma has also been developed to detect dengue fever and malaria.
(i) Dengue fever is caused by a virus that enters the body through the bite of an infected mosquito. It binds itself to WBCs and replicates within the cells. In 2012, researchers from Pakistan published a preliminary Raman study (442 nm and 532 nm excitations) that compared normal dried serum with dried serum from a dengue patient. 187 Dengue serum showed two peaks at 1614 and 1750 cm À1 , assigned to the presence of immunoglobulin (Ig) G and IgM antibodies. The same group extended their Raman work in 2013 (532 nm excitation) and again in 2016 by including more serum samples and introducing a multivariate analysis for spectral discrimination. Carotenoid bands in the dengue-infected blood sera disappeared, implying that anti-oxidant protection for cell membranes is diminished. Their discrimination model was tested for six unknown human blood serum samples and produced 100% accuracy in accordance with clinical results. 188, 189 (ii) Malaria is caused by Plasmodium parasites and transmitted via mosquitoes. As described above (Malaria), most Raman spectroscopy studies of malaria seek to describe the infected erythrocytes, an approach that requires time to scan or image an entire blood smear. The alternative to this traditional approach is to use Raman spectroscopy to measure plasma or serum, which has the advantage of measuring malaria-specific changes against a background that is hampered by less masking from cellular hemoglobin. One study, which has already been mentioned above, produced results from malaria-infected plasma that did not show a clear trend with respect to time after infection. 106 A more recent study compared spectra from plasma of patients infected with malaria to those infected with dengue fever. The results showed a Raman line associated with b-carotenoids to be present in healthy patients, but that its intensity decreased substantially in the case of malaria and completely disappeared in dengue-infected samples. 190 Other diseases or conditions that have been studied using plasma include brain ischemia (insufficient blood flow to the brain), 191, 192 hepatitis C (disease of the liver), 193 pemphigus vulgaris (skin disease) 194 and preeclampsia (a condition that can occur during pregnancy). 195 Early investigations of plasma in asthma (lung inflammation) 196 and Alzheimer's disease (a form of dementia) 197, 198 have also been performed.
Whole Blood
To the first approximation, a unit volume of human blood comprises $50% plasma (mostly water, a weak Raman scatterer), 40-45% RBCs (mainly composed of hemoglobin) and a relatively small proportion of WBCs/platelets. Thus, with $150 g of highly scattering hemoglobin in each liter of whole blood, it is no surprise that the metalloprotein dominates the Raman spectrum and makes analysis of other chemical species difficult. 34 The difficulty has not deterred workers from undertaking Raman analysis of whole blood, however; in 1992 Ozaki et al. used FT-Raman (1064 nm excitation) to obtain a spectrum of whole blood and compared the result to that of coagulated (via laser irradiation) whole blood. The spectra showed that the amide I band had shifted, an indication that hemoglobin was denatured (a-helix structures becoming random coil structures). 34 In 1997, related work by Schrader et al. would demonstrate the obvious similarities between Raman features of whole blood and those of erythrocytes ( Figure 13 ). 199 Ozaki and colleagues would later use three separate excitation wavelengths (514.5 nm, 720 nm, and 1064 nm) on samples of whole blood and isolated hemoglobin to determine that the 720 nm excitation yielded strong Raman scattering of carotenoids and protein. The wavelength was also shown to give a Raman spectrum of the heme-chromophore, free from florescence interference. 200 Later work (785 nm excitation) by another group would conclude that dried whole human blood produced spectra with features exclusive to oxyHb, and that hemoglobin aggregation/denaturation would occur if stimulated with an excitation power over 2 mW. The bands associated with these laser-induced effects in whole blood agreed with similar aggregation/ denaturation bands assigned by previous research groups in samples of isolated RBCs. 201 As mentioned above, the detection and monitoring of glucose in blood has been a prime target for many scientists because of its importance to diabetes medicine. One of the pioneers in the Raman detection of glucose in whole blood was MIT's Michael Feld. In 1997, his team reported on the feasibility of using Raman spectroscopy (830 nm excitation) to determine spiked concentrations for above-physiological glucose levels in whole blood. 202 This work was developed so that the superimposed bands of the analyte could be resolved (preliminary processing of the spectra, with no correction for turbidity, produced significant prediction accuracy for four of six analytes but not for glucose, and these spectra had a lower signal-to-noise ratio than the same analysis performed in serum). 153 A 2002 report described an optimized Raman measurement for turbid samples and showed the first quantitative observation of multiple analytes (including glucose) in whole blood. 203 The wholeblood studies described to this point mainly utilized conventional Raman spectroscopy, but recently some of the more specialized techniques have also been used in the field. In 2008, researchers from Princeton, NJ utilized CARS to record Raman lines associated with RBCs from oxygenated blood, and the identified vibrational modes were in very good agreement with previously published data. As is the case for CARS work, the actual shifts for the Raman lines were preserved, while the relative intensities in the CARS spectra differed from the spontaneous analog. The use of CARS, however, meant that spectra could be recorded very quickly and there was no need for microscopy setups, isolation of RBCs, chemical preparation, or long integration times. 204 In 2011, a SERS analysis of whole blood was reported by researchers in Italy. Their work showed that conventional Raman spectroscopy and SERS favored different bands at different excitation wavelengths (b-carotene at 514 nm excitation and hemoglobin at 785 nm excitation), so one could selectively probe either b-carotene or hemoglobin bands at 514 nm depending on whether SERS conditions were created (i.e., hemoglobin markers showed up in SERS at 514 nm excitation). 205 Similar phenomena were reported in 2012, when Premarisi et al. showed that the SERS spectrum of whole blood had a storage time-dependence that was not evident in the conventional Raman spectroscopy of whole blood. 50 Forensic Science. Raman spectroscopy of blood has not been solely concerned with the biochemical, biological, and medical domains, as it has also been developed as a forensic tool. In 2008, researchers from Belgium used Raman spectroscopy to analyze miniscule particles of coagulated blood that had been collected with a standard crime-scene tapelifting technique. They compared four different excitation wavelengths (488 nm, 514.5 nm, 632.8 nm, and 752.6 nm); each had had different enhancements but none could provide a spectral differentiation between blood particles of human, feline, or canine origin. 206 That same year, Igor Lednev and his coworkers published a spectrum for dried whole blood at 785 nm excitation, 207 followed by a demonstration that multivariate analysis could be used to differentiate human, feline, and canine blood within a confidence interval of 99%. 208 The study was later repeated on a larger scale with blood from 12 animal species. 209 In 2010, the same group showed that spectra obtained from multiple spots on the same dried sample were chemically heterogeneous and that the relative contribution of the dominant hemoglobin and fibrin bands varied with each donor. 210 The assignment of certain bands to fibrin was later revised 211 as more was learned about the effect of intense laser exposure. 201 After understanding of the chemical heterogeneity of blood spatters increased, Lednev et al. proposed that multi-dimensional Raman measurements be attempted, 212 and in 2012 they used the technique to discriminate between dry samples that contained mixtures of human blood and semen. With their multivariate algorithm, mixtures with blood content higher than 80% could not be distinguished from pure blood, while 5% blood in a mixture resulted in a Raman spectrum distinguishable from the spectrum of pure semen 213 (later studies would report on the successful discrimination between dry samples of peripheral blood and menstrual blood, 214 and also between races 215 ).
Raman spectroscopic analysis of blood is affected when the spatter dries on a non-ideal substrate such as fabric. Bodily fluids are weak-to-moderate Raman scatterers, and often the substrates can contribute a dominant Raman or fluorescence signal. 216 Lednev et al. proposed solutions to this problem (such as varying the excitation laser source and selecting the wavelength that produced the least luminescence for that particular substrate) 217 and they reported statistical methods for reducing the interference. 218 In 2012 Boyd et al. reported a study that showed SERS substrates can be used as swabs to collect blood at a crime scene, and they demonstrated a sensitivity comparable to traditional chemical-based identification techniques. 219 In 2012, a case of Raman spectroscopy being used in an actual murder investigation was reported by Janko et al.; they identified hemoglobin in a tissue sample excised from Ö tzi, the 5300-year-old ''Iceman'' whose preserved remains were found near the border of modern-day Austria and Italy in 1991. 220 Disease Detection. Detection of disease using Raman spectroscopic analysis of whole blood is the obvious end goal for many of the studies outlined above. Some researchers have gone directly to whole blood and used nonstandard techniques to isolate compounds of interest. In 1999, researchers at the University of Wyoming implemented a SERS assay that used an analyte-specific reactive coating to trap the molecule of interest and then perform SERS (632 nm excitation) to selectively enhance its spectrum. Their approach required less time and effort than standard processing of whole blood and enabled bilirubin and salicylate (compounds associated with jaundice and poisoning) to be probed within the blood. 221 In 2004, whole blood from scrapie-infected sheep (a fatal, degenerative disease that affects the nervous systems of sheep and goats, related to bovine spongiform encephalopathy, ''mad cow disease'') was collected and processed (subjected to centrifugation and osmotic shock) to produce pellets rich in pathogenic prion proteins. These pellets were analyzed with Raman spectroscopy (1064 nm excitation) and the data from 31 infected sheep were shown to be statistically different than those from 150 healthy controls (no features attributable to b sheet content were present in the controls). 222 In 2011, researchers in Taiwan created SERS-based (632 nm excitation) multi-functional biochips (silver nanoparticle substrates coated with vancomycin) for rapid detection of micro-organisms in blood samples spiked with clinically relevant bacteria. However, this method was hampered by the necessity for chemical immobilization on the SERS-active substrate, a long incubation time, and repeated wash steps to remove non-specifically bound cells. 223 A later study coupled a compact hybrid electrokinetic mechanism (to exclude blood cells from the matrix) with a SERS-chip substrate to address these problems. 224 
In Vivo Raman Spectroscopic Analysis of Blood
If the Raman spectroscopic analysis of whole blood is the end goal of many of the studies described above, then the ultimate end point for many of them must be the Raman spectroscopic analysis of whole blood in vivo. For example, the development of a non-invasive, transcutaneous glucose monitor would eliminate the need for diabetics to have blood sampled multiple times a day. Thus far, hemoglobin and blood metabolites (such as glucose) have attracted the most attention for in vivo measurements.
In Vivo Raman Spectroscopic Analysis of Hemoglobin. Some of the earliest work on in vivo whole blood Raman spectroscopic analysis was reported by Chaiken et al. in conference proceedings of the SPIE. The work involved the application of physical pressure to the fingertip (to produce an ''unsqueezed'' state, blood flow-normal, and a ''squeezed'' state, blood flow-altered), and Raman probing of the skin (785 nm and 830 nm excitation). The spectral differences found from the tissue modulation were not assigned to chemical species, but the analysis was performed on diabetic patients and said to be capable of measuring physiological variations in glucose. 225, 226 It was later shown that this approach was highly sensitive to an individual's peripheral microcirculation 227, 228 and the test subject's hemoglobin concentration. 229 Much of the early work on the in vivo analysis of hemoglobin oxygenation for surgical applications was carried out by Torres Filho et al. They reported the utility of UV-RRS for the simultaneous identifications of oxyhemoglobin and deoxyhemoglobin in the microvessels of a living rat using a single excitation wavelength (406.5 nm in one study, 230 and 532 nm in another 231 ). When the rat's hemoglobin saturation (as measured by a commercial oximeter) was <1% (deoxygenated) or >98% (oxygenated), a single Raman peak was observed. For intermediate levels of saturation, the spectra showed two clearly defined hemoglobin peaks in the range 1350-1400 cm À1 . These observations were consistent with the very first Raman spectroscopic studies of hemoglobin carried out by Spiro, Brunner, etc. and outlined above. Torres Filho and colleagues continued this work (using the sublingual mucosa of rats) and published the first pilot study of RRS (406.5 nm excitation) to track microvascular hemoglobin oxygenation in tissue during hemorrhage ( Figure 14 ) and resuscitation. 232, 233 The technique compared well with other important indicators of tissue oxygenation, such as central venous oxygen saturation and lactate concentration, among others. It was concluded that the ability to determine hemoglobin saturation depended on the amount of tissue present in the light path, and that the optical signal would be too weak to be detected if the layer was too thick. Other investigators have also tackled the challenge of attempting in vivo measurements of blood.
Recently, Shao et al. used optical tweezers (785 nm) to capture single RBCs in the microvessel of a mouse ear; their data relied on well-characterized hemoglobin modes, which indicated that RBCs in arterioles were oxygenated, while those in the capillaries of venules were deoxygenated. 234 Their next paper expanded on this work to involve glucose measurements, as direct spectral evidence of its presence was indicated by a characteristic peak at 1125 cm À1 . Using the concentration of hemoglobin as an internal standard, the impact of complexity (i.e., diversity of both tissues and individuals) was reduced and clearly showed a relationship between Raman intensity and glucose concentration in mouse blood. 235 In Vivo Raman Spectroscopic Analysis of Metabolites. One of the earliest in vivo Raman spectroscopic studies of blood metabolites saw researchers from Brazil inject a rat with 1 mL of a concentrated lactic acid aqueous solution (120 mM) and use an optical fiber cable to record the spectrum of the analyte through the skin of the rat groin. 164 It was outlined above how, in the late 1990s and early 2000s, Feld et al. used Raman spectroscopy to detect and measure analytes (such as glucose) in whole blood. In 2005, three years after their last in vitro study was reported, the same group reported the first successful study of Raman spectroscopy (830 nm excitation) for quantitative, non-invasive measurement of blood glucose from the forearms of 17 healthy human subjects. In order to measure glucose concentrations in human skin, it was necessary to sample the innermost skin layer; the penetration depth of 830 nm excitation light was shown to be sufficient for this as the Raman spectra collected from the forearms were dominated by collagen (the major component of dermis). The underlying subcutaneous fat was also sampled, as the second largest contribution to the data was shown to be from triglyceride. 236 Feld et al. found that their attempts to translate Raman spectroscopy to clinical settings were impeded by the lack of robust calibration models and the complexity of the blood/tissue spectra. It became clear that in order to tackle these problems and extract useful information, multivariate analyses of the data were needed. Furthermore, in addition to the generic problems associated with multivariate data analyses (system drift, covariations between constituents, overfitting, etc.) blood applications were limited by variations in sample turbidity. In 2009, they presented turbidity-corrected Raman spectroscopy (TCRS), a technique that required alternate acquisition of diffuse reflectance and Raman spectra, and corrected for intensity and shape distortions. 237 In 2011, in what were now posthumous publications for the group leader, a revised version of TCRS was reported that incorporated residue error plot-based wavelength selection and nonlinear support vector regression (SVR). In these experiments, wavelength selection was used to eliminate uninformative regions of the spectrum (and thus reduce the collection time of Raman acquisition), and the SVR was used to model the curved effects such as those created by tissue turbidity and temperature fluctuations. 238 The following month, it was reported that an adapted instrumental set-up in transmission mode had been used to collect Raman spectra (830 nm excitation) from the hands (thenar skin fold) of 18 human volunteers. The subjects ingested a glucose-rich beverage to induce changes in blood glucose levels, and the spectral quantitation was shown to compare well with glucose levels measured using conventional finger-stick glucometers. 239 
Conclusions
This review has outlined many of the ways in which Raman spectroscopy has been used to evaluate blood components and/or whole blood. It has been shown that the earliest work in the field was associated with the structural characteristics of hemoglobin (e.g., its degree of oxygenation and the oxidation state of its iron atoms) and that this work laid the groundwork for RBC studies over the following decades. The earliest Raman spectroscopic work on WBCs characterized cell composition of various cell subtypes (major components identified were carotenoids, enzymes, lipids, and nucleic acids) and explored the intracellular distribution of substances within the nucleus and cytoplasm. The most effective procedures involved laser trapping and multivariate analyses; such reports demonstrated ''Raman-based cell classifiers'' that were capable of sorting WBCs from one another and, more importantly, from deleterious cells such as tumor and cancer cells.
It has been shown that the chemical composition of plasma (and serum) has received considerable attention from the Raman community due to its inherent utility as a barometer of the body's health. The earliest results showed the ability to detect relevant metabolites (glucose, cholesterol, triglyceride, urea, total protein, albumin, lactic acid, etc.) and more recent work has focused on resolving relevant biomarkers (nucleic acid and carotenoid intensity changes in cancer patients) using multivariate models. Raman spectroscopy investigations of whole blood are not as advanced as some blood component work because the spectrum is dominated by hemoglobin. There has been some interesting work, however, in the forensic field where Raman spectroscopy has shown promise for discriminating between the blood of different species and also from other bodily fluids. The other main direction of whole-blood Raman work has been in vivo analysis, especially efforts to develop a transcutaneous glucose monitor.
Taken together, the literature demonstrates how a trail of research that began in the 1970s with basic research using highly specialized instrumentation has travelled all the way to the present day where real-time in vivo Raman monitoring of RBC oxygenation/deoxygenation, glucose detection, and disease diagnosis are on the cusp of being realized. 
Limitations in Raman Blood Research
Generic Raman problems (i.e., those associated with fluorescence and the inherent weakness of the Raman effect) limit its application in all fields, none more so than the study of blood; the selection of a suitably long excitation wavelength can alleviate the former but with the drawback of aggravating the latter (the intensity of Raman scatter being inversely proportional to the fourth power of the excitation wavelength). In many situations the weak signal cannot by amplified by increasing the laser power because of the fragile nature of the biochemical cells (i.e., the constant risk of photodegradation or thermal damage) and many of the papers in this review focused on using specialized variants of Raman spectroscopy to circumvent these problems (e.g., using RRS to enhance the signal from specific components).
There are other limitations that are specific to Raman spectroscopic analysis of RBCs/whole blood and purified plasma/serums. These are related to dominant signals from specific components (hemoglobin in the former, macro proteins in the latter) that overwhelm and overlap the signal of interest.
Statistical Power Derived from Experiments. Numerous diseases, such as diabetes, malaria, sickle-cell anemia, and even particular types of cancers, induce concomitant changes in the chemical composition of blood. Clinical diagnosis of these diseases can involve time-consuming, expensive and/or invasive analyses that could be replaced with Raman spectroscopy if the technology was suitably developed and the analysis methodology became reliable. In order to bridge the gap between the spectroscopic research community and clinicians, a new approach and a greater weight of evidence will be needed. For example, in the blood transfusion community there has long been a hypothesis that RBCs that are stored for weeks have deleterious effects on a patient post-transfusion; in 2015, the New England Journal of Medicine published the results of the ''Age of BLood Evaluation (ABLE)'' trial, a multi-center, randomized, blinded trial, in which critically ill adults were assigned to receive RBCs that had either been stored for less than eight days, or standard-issue RBCs (the oldest compatible units available in the blood bank). The study took place at 64 centers throughout Canada, the UK, France, the Netherlands, and Belgium and the number of patients tracked (n) was 1211 (the primary outcome measured was 90-day mortality). The conclusion of the study was that (surprisingly) the storage-age of the blood had no effect and the transfusion of fresh red cells, as compared with standard-issue red cells, did not decrease the 90-day mortality among critically ill adults. 240 No Raman spectroscopic study reviewed in this manuscript carries a weight of evidence that is comparable to the ABLE trial (n in a typical Raman study might be <100), and for spectroscopic techniques to begin to appeal to the readers of the New England Journal of Medicine and make the jump from the laboratory to the hospital or clinic, this discrepancy will have to be addressed.
Final Conclusions
Raman spectroscopy, when combined with multivariate analysis, can enable rapid distinction between subtypes of WBCs, and distinction in both healthy and diseased states. The final objective for many Raman spectroscopic studies of blood and blood components is to achieve a method for such a rapid and inexpensive analysis, but with the additional expectation that it can be performed non-invasively. Current glucose-monitoring techniques used by diabetics, for example, require the extraction of a drop of blood, normally obtained via finger prick; a non-invasive Raman spectroscopic analysis is being actively pursued by a number of research laboratories.
